Team





NAME

TITLE

OFFICE

GROUP

 Edmund Lazarus

 Managing Partner

 London

 Bregal Capital

Edmund was a Founding Partner of Bregal Capital from inception in 2002. He sits on our Investment Committee and on the Boards of Cognita, Danwood, Morrison, Novem, QA, Reconomy and Studialis. He led our successfully exited investments in Zephyr and GSL.

Before founding Bregal Capital, Edmund worked at Morgan Stanley Capital Partners, where he was a member of the firm's global Investment Committee, SG Warburg and Merrill Lynch. Edmund graduated from Oxford University with a First Class degree in politics, philosophy and economics, where he also served as President of the Oxford Union.

In parallel with his professional career, Edmund was a publicly-elected official on Westminster City Council from 1992 to 2002, including serving as Deputy Leader and Chairman of Finance. Edmund was nominated by the Mayor of London to Chair the Investment Committee of the London Development Agency from 2008 to 2012 and to help restructure the Agency. Edmund currently Chairs the London Green Fund.

 Joy Bainville

 Partner

 London

 Bregal Capital

Joy is involved in our investments in Studialis, Cognita and Cerigo.

Before joining Bregal Capital, Joy worked in the investment banking division of Morgan Stanley, where she focused on M&A and equity transactions. Joy graduated from HEC in France, majoring in finance.

 Patrik Johnson

 Partner

 London

 Bregal Capital

Patrik played an active part in Bregal Capital's investments in Bluestep, Cognita, Danwood and MCi and currently sits on the board of Bluestep, Cognita and Danwood.

Prior to joining Bregal Capital, Patrik worked for Credit Suisse First Boston in London. He graduated from the Stockholm School of Economics with a degree in accounting and financial management, and also completed studies at the university of St. Gallen, Switzerland.

 Olivier Morali

 Partner

 London

 Bregal Capital

Olivier leads the firm's investment in Studialis and sits on the board of Morrison which he has been involved with since inception. Formerly, he was on the boards of MCi and Cerigo.

Before joining Bregal Capital, Olivier was a Director at Apax Partners in Paris, where for five years he focused primarily on healthcare investments. Prior to that, he worked for Arthur Andersen. Olivier holds a PhD and a doctorate in biology/biochemistry from Paris University and is a graduate of the Ecole Normale Superieure.

 Dwight Cupit

 Partner and Chief Financial Officer

 London

 Bregal Capital

Dwight is responsible for all aspects of the back office and finance function of the firm.

Before joining Bregal Capital, Dwight was the Finance Director of eVolution Global Partners, a start-up venture capital firm sponsored by Kleiner, Perkins, Texas Pacific Group and Bain & Co and started his career at Arthur Andersen. Dwight is a Chartered Accountant and graduated from Monash University, Melbourne, with a Bachelor in Economics.

 Michele Fontana Sabatini

 Investment Director

 London

 Bregal Capital

Michele works on our investment in Cognita and currently sits on the board of QA. He also worked on our investment in MCi which has been successfully sold. 

Before joining Bregal, Michele worked in the investment banking division of Merrill Lynch, where he focused on M&A and corporate finance transactions. Michele graduated from Bocconi University in Italy with a degree in business administration and has an MBA from the Wharton School.

 Giles Marshall

 Investment Manager

 London

 Bregal Capital

Giles works on our investments in Danwood, Five Ten, Ideal Stelrad, Morrison and Reconomy.

 

Before joining Bregal, Giles worked at UBS in the UK Investment Banking and Real Estate Investment Banking teams. Giles graduated from Durham University with a degree in Classics.

 Nicholas Armstrong

 Associate

 London

 Bregal Capital

Nicholas works on our investment in Reconomy.

Before joining Bregal, Nicholas worked at Nomura in the UK M&A Investment Banking and Australia Investment Banking teams. Nicholas graduated from the University of Sydney with a master’s degree in finance.

 Tom Carroll

 Associate

 London

 Bregal Capital

Tom works on our investments in Danwood, Five Ten, Morrison and Whittan.


Before joining Bregal, Tom worked at Bank of America Merrill Lynch in the healthcare investment banking team.  Tom graduated from Imperial College London with a master’s degree in physics.

 Adam Frahm

 Associate

 London

 Bregal Capital

 

Adam works on our investments in Bluestep, Cognita and Whittan.

 

Before joining Bregal, Adam worked in the investment banking division of Citigroup, focusing on M&A and corporate finance transactions in the financial sponsors space. He graduated from Copenhagen Business School with a master’s degree in finance and strategic management.

 Gilles Gradassi

 Associate

 London

 Bregal Capital

Gilles works on our investments in QA and Studialis.

 

 

Prior to joining Bregal Capital, Gilles worked at Credit Suisse, specialising in M&A and corporate finance transactions in EMEA primarily across the Industrials and Energy sectors. Gilles graduated from Ecole Centrale Paris with a degree in industrial engineering.

 Sofian Lignier

 Associate

 London

 Bregal Capital

Sofian works on our investments in Ideal Stelrad and Studialis.

 

Before joining Bregal, Sofian worked in the investment banking division of Credit Suisse for close to four years. He was originally based in Dubai and worked on a number of M&A and corporate finance transactions as part of their Middle East advisory team. In late 2012 he relocated to London to join their Energy team. Sofian graduated from the Ecole des Mines de Paris with a master’s degree in engineering.



 
Opto Circuits India Management Call swiss replica watches It a pleasure to present to you minutes of our extensive discussion with Opto Circuits Management. Mr Vinod Ramnani MD, Mr Bodapeti Bhaskar omega replica CFO, and Mr. Valiveti Bhaskar Dir Operations, participated in this free-wheeling discussion over almost hublot replica 3 hours. MRI+multi-parameter monitor and OEM manufacturing deals-just announceda) Some of these off-the-record developments discussed last time, cartier replica have panned out. Can you tell us more about the deal? What is unique about this deal/product Opto Circuits has signed omega replica a strategic long term agreement with a European manufacturer and distributor replica watches uk of medical equipment. The agreement involves the supply of private label patient monitoring systems by us to rolex replica the partner integrating Criticare modular anesthetic gas delivery products (in their product) for several key markets replica watches, both in the United States and Europe. This should be a significant driver of revenue growth? What will be the near-term cartier replica and medium-term impact? What kind of margins can we expect here? Opto Circuits retains the rights for the Indian market. rolex replica This is a strategic long term deal louis vuitton replica with the manufacturer. This deal replica handbags means that we are assured of some bulk quantities and do not have to go through the distribution route ourselves. chanel replica The margins we will be thinner, but we are spared the higher working capital requirements for omega replica the same, which as you know can be considerable with longer credit cycles for distributors. Is this rolex replica a game changer, will it lead to more pure OEM deals?